Pneumococcal 24-Valent Conjugate Vaccine（Fosun Adgenvax Biopharma）
24价肺炎球菌多糖结合疫苗（复星安特金）
Report date: 2025/03/04 11:26:53
Base Information
Drug NamePneumococcal 24-Valent Conjugate Vaccine（Fosun Adgenvax Biopharma）
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesFosun Adgenvax Biopharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesFosun Adgenvax Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A